glp 1 muscle mass loss Study finds GLP-1 receptor agonists target fat over for weight GLP-1 drugs for weight loss:

The study showed a 13% reduction in major adverse cardiovascular events (MACE), a composite endpoint for cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke, in patients treated with liraglutide compared with placebo at a mean follow-up of 3.8 years (hazard ratio [HR] 0.87, 95% confidence interval [CI] 0.780.97) and a significant reduction in cardiovascular death (HR 0.78, 95% CI 0.660.93)

The second group ends up lighter but weaker, with a slower metabolism and a higher probability of regaining the weight

Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH) is a highly selective, synthetic ghrelin mimetic and one of the cleanest growth hormone-releasing peptides (GHRPs) available for research

Zinc deficiency affects DNA damage, oxidative stress, antioxidant defenses, and DNA repair in rats

The short answer is yes, but results are better with some activity